Southpoint Capital Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$33.8M	Hold	4,077,214	–	–	0.85%	31
2025 Q1	$24.8M	Hold	4,077,214	–	–	0.59%	37
2024 Q4	$25.8M	Hold	4,077,214	–	–	0.6%	36
2024 Q3	$20.4M	Hold	4,077,214	–	–	0.48%	38
2024 Q2	$24.9M	Hold	4,077,214	–	–	0.62%	37
2024 Q1	$45.3M	Hold	4,077,214	–	–	0.9%	37
2023 Q4	$45.7M	Hold	4,077,214	–	–	0.98%	32
2023 Q3	$30.6M	Hold	4,077,214	–	–	0.68%	38
2023 Q2	$36M	Hold	4,077,214	–	–	0.78%	35
2023 Q1	$33.9M	Hold	4,077,214	–	–	0.77%	38
2022 Q4	$39.1M	Hold	4,077,214	–	–	1.01%	26
2022 Q3	$33M	Hold	4,077,214	–	–	0.89%	30
2022 Q2	$22.8M	Hold	4,077,214	–	–	0.65%	32
2022 Q1	$22.8M	Hold	4,077,214	–	–	0.44%	41
2021 Q4	$17.9M	Hold	4,077,214	–	–	0.34%	44
2021 Q3	$38.4M	Hold	4,077,214	–	–	0.82%	33
2021 Q2	$29.7M	Hold	4,077,214	–	–	0.52%	41
2021 Q1	$25.3M	Hold	4,077,214	–	–	0.41%	48
2020 Q4	$30.4M	Hold	4,077,214	–	–	0.53%	35
2020 Q3	$24.7M	Hold	4,077,214	–	–	0.56%	34
2020 Q2	$34M	Buy	4,077,214 +80,000	+2%	+$668K	0.83%	34
2020 Q1	$23.7M	Hold	3,997,214	–	–	0.69%	30
2019 Q4	$25.9M	Hold	3,997,214	–	–	0.93%	25
2019 Q3	$19.2M	Hold	3,997,214	–	–	0.73%	26
2019 Q2	$16M	Hold	3,997,214	–	–	0.6%	28
2019 Q1	$19.4M	Hold	3,997,214	–	–	0.82%	26
2018 Q4	$25.5M	Hold	3,997,214	–	–	1.23%	24
2018 Q3	$32.8M	Hold	3,997,214	–	–	1.27%	25
2018 Q2	$41.7M	Hold	3,997,214	–	–	1.77%	21
2018 Q1	$48.3M	Hold	3,997,214	–	–	2.14%	20
2017 Q4	$40.1M	Hold	3,997,214	–	–	1.91%	26
2017 Q3	$44.3M	Buy	+3,997,214	New	+$44.3M	1.82%	19